Jefferies Lifts PT on Integra LifeSciences (IART) to $46

February 22, 2013 8:20 AM EST Send to a Friend
Get Alerts IART Hot Sheet
Price: $52.92 +0.82%

Rating Summary:
    9 Buy, 12 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade IART Now!
Join SI Premium – FREE
Jefferies bumped its price target on Buy-rated Integra LifeSciences (NASDAQ: IART) from $43 to $46 following Q4 results.

The firm comments, "Integra reported somewhat disappointing 4Q results, with all US businesses underperforming and lower profit margins relative to our model. And while the Puerto Rico FDA warning letter is certainly an unwelcome development, the company’s long-term strategy for revenue growth acceleration and margin expansion is notable and 2013 guidance looks achievable."

The firm trimmed FY13 EPS from $3.26 to $3.17.

For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.

Shares of Integra LifeSciences closed at $40.34 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment